Search
Hip Arthroscopy | UTSW Medical Center
https://utswmed.org/conditions-treatments/hip-arthroscopy/
Hip arthroscopy is a minimally invasive surgery used to treat pain in the hip joint. Learn more about hip arthroscopy from UTSW’s orthopedic hip specialists.
Hip Arthritis | UTSW Medical Center
https://utswmed.org/conditions-treatments/hip-arthritis/
Hip arthritis is a common cause of pain in the hip joint. Learn about the causes, types, and symptoms of hip arthritis.
Women's Heart Health | Conditions & Treatments | UT Southwestern Medical Center
https://utswmed.org/conditions-treatments/womens-heart-health/
Heart specialists at UT Southwestern provide tailored care specifically for women with heart diseases such as coronary artery disease and broken heart syndrome.
Demystifying Tumor Biology of Hepatocellular Carcinoma | Gastrointestinal Cancer | Population Science | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/demystifying-tumor-biology-hepatocellular-carcinoma/
UT Southwestern sought to better characterize the tumor biology and natural history of HCC in a U.S. population. Here are the recent findings from this research.
Expanding Eligibility Criteria for Cancer Clinical Trials | Clinical Trials | Lung Cancer | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/expanding-eligibility-criteria-cancer-clinical-trials/
A history of previous cancer often prevents patients from participating in clinical trials. UT Southwestern is changing this and expanding eligibility.
Enhancing Immunotherapy Drug Trials for Patients with Breast Cancer | Breast Cancer | Clinical Trials | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/enhancing-immunotherapy-drug-trials-patients-breast-cancer/
When treating a patient with breast cancer, how do we maximally stimulate immune cells to recognize and kill tumor cells? UT Southwestern is finding the answer.
Novel Biomarker Might Lead to Personalized, Targeted Therapy | Gynecologic Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/novel-biomarker-might-lead-personalized-targeted-therapy/
ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients. Learn how UT Southwestern is advancing this research.
Progressing Therapeutic Options for Chronic Lymphocytic Leukemia | Hematologic Malignancies | Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/progressing-therapeutic-options-chronic-lymphocytic-leukemia/
The treatment landscape of chronic lymphocytic leukemia has changed remarkably in recent years. Learn how UT Southwestern is developing next-generation treatment.
The Evolving Role of CAR T-Cell Therapy in Multiple Myeloma | Hematologic Malignancies | Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/evolving-role-car-t-cell-therapy-multiple-myeloma/
Learn how UT Southwestern is advancing this novel immunotherapeutic approach, which holds the potential to change the treatment landscape of many cancers.
Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients | Gastrointestinal Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/adjuvant-chemotherapy-colon-cancer/
Researchers at UT Southwestern set out to understand the under-utilization of ACT in stage three colon cancer patients. Learn the impact on patient outcomes here.